- In 2024, 40.8 million people were living with HIV, and 1.3 million people newly acquired HIV
- The IAVI/Scripps Research HIV vaccine development strategy aims to coach the immune system…
IAVI announces first vaccinations in IAVI G004, a Phase 1 clinical trial of a promising HIV vaccine approach
